VVOS

Vivos Therapeutics, Inc. VVOS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VVOS BBLG TIVC BJDX RPID NAOV TLIS NUWE HSCS
6M 33.91 % -45.27 % -33.87 % 20.83 % 58.91 % -90.66 % -14.29 % -91.06 % 1.16 %
YTD -26.59 % -58.74 % -50.43 % -30.35 % 226.52 % -90.73 % -11.76 % -93.06 % -6.68 %
1Y 26.83 % -74.53 % -26.09 % -41.47 % 262.30 % -90.73 % -11.20 % -94.00 % -2.51 %
3Y -81.24 % -99.35 % -99.89 % -99.95 % 1.26 % -99.35 % -85.41 % -99.99 % -97.29 %
5Y -98.61 % -99.93 % -99.97 % -99.99 % -85.00 % -99.59 % -99.64 % -100.00 % -97.95 %
10Y -98.61 % -99.93 % -99.97 % -99.99 % -85.00 % -99.93 % -99.64 % -100.00 % -97.95 %
From the beginning -98.61 % -99.93 % -99.97 % -99.99 % -85.00 % -99.92 % -99.64 % -100.00 % -97.95 %

Dividend